CUSIP: 163572209
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,833,298
-
Share change
-
+268,396
-
Total reported value
-
$15,013,000
-
Price per share
-
$8.19
-
Number of holders
-
25
-
Value change
-
+$2,322,776
-
Number of buys
-
18
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 163572209:
Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q2 2016
As of 30 Jun 2016,
CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,833,298 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, EAM Investors, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, Blue Clay Capital Management, LLC, BlackRock Fund Advisors, TAURUS ASSET MANAGEMENT, LLC, THOMPSON DAVIS & CO., INC., and DEUTSCHE BANK AG\.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.